In our scRNA-seq data, NK cells in tumor tissue showed higher expression of NKG2A and KIRs, including KIR2DL1, on a larger percentage of NK cells in patients with less pathological regression, suggesting that these subsets impair responses to anti-PD-L1. This evidence concerns the gene KIR2DL1 and neoplasm.